CU24172B1 - Sistemas terapéuticos transdérmicos con lámina de protección inhibidora de la cristalización - Google Patents

Sistemas terapéuticos transdérmicos con lámina de protección inhibidora de la cristalización

Info

Publication number
CU24172B1
CU24172B1 CU20130031A CU20130031A CU24172B1 CU 24172 B1 CU24172 B1 CU 24172B1 CU 20130031 A CU20130031 A CU 20130031A CU 20130031 A CU20130031 A CU 20130031A CU 24172 B1 CU24172 B1 CU 24172B1
Authority
CU
Cuba
Prior art keywords
protection sheet
transdermal therapeutic
therapeutic systems
crystallization inhibiting
inhibiting protection
Prior art date
Application number
CU20130031A
Other languages
English (en)
Spanish (es)
Other versions
CU20130031A7 (es
Inventor
Estefan Bracht
Ildiko Terebesi
Thomas Langguth
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44653285&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CU24172(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of CU20130031A7 publication Critical patent/CU20130031A7/es
Publication of CU24172B1 publication Critical patent/CU24172B1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CU20130031A 2010-09-06 2011-09-02 Sistemas terapéuticos transdérmicos con lámina de protección inhibidora de la cristalización CU24172B1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102010040299A DE102010040299A1 (de) 2010-09-06 2010-09-06 Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
PCT/EP2011/065204 WO2012031985A1 (de) 2010-09-06 2011-09-02 Transdermale therapeutische systeme mit kristallisationsinhibierender schutzfolie (release liner)

Publications (2)

Publication Number Publication Date
CU20130031A7 CU20130031A7 (es) 2013-05-31
CU24172B1 true CU24172B1 (es) 2016-04-25

Family

ID=44653285

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20130031A CU24172B1 (es) 2010-09-06 2011-09-02 Sistemas terapéuticos transdérmicos con lámina de protección inhibidora de la cristalización

Country Status (33)

Country Link
US (2) US8557279B2 (enExample)
EP (1) EP2613771A1 (enExample)
JP (2) JP6104800B2 (enExample)
KR (1) KR20130114127A (enExample)
CN (1) CN103079549B (enExample)
AP (1) AP3586A (enExample)
AR (1) AR082907A1 (enExample)
AU (1) AU2011298892B2 (enExample)
BR (1) BR112013005305A2 (enExample)
CA (1) CA2810103C (enExample)
CL (1) CL2013000636A1 (enExample)
CO (1) CO6690753A2 (enExample)
CR (1) CR20130098A (enExample)
CU (1) CU24172B1 (enExample)
DE (1) DE102010040299A1 (enExample)
DO (1) DOP2013000053A (enExample)
EA (1) EA032575B1 (enExample)
EC (1) ECSP13012477A (enExample)
GT (1) GT201300062A (enExample)
IL (2) IL224980A (enExample)
MA (1) MA34581B1 (enExample)
MX (1) MX2013002602A (enExample)
MY (1) MY162768A (enExample)
NZ (1) NZ607630A (enExample)
PE (2) PE20131138A1 (enExample)
PH (1) PH12013500429A1 (enExample)
SG (2) SG10201506927TA (enExample)
TN (1) TN2013000087A1 (enExample)
TW (1) TWI576245B (enExample)
UA (1) UA110217C2 (enExample)
UY (1) UY33590A (enExample)
WO (1) WO2012031985A1 (enExample)
ZA (1) ZA201301389B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI630208B (zh) 2008-12-08 2018-07-21 歐陸斯迪公司 二氫羥戊甲嗎啡
GB201309654D0 (en) 2013-05-30 2013-07-17 Euro Celtique Sa Method

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH674618A5 (enExample) * 1987-04-02 1990-06-29 Ciba Geigy Ag
DE58909570D1 (de) 1988-10-27 1996-02-22 Schering Ag Mittel zur transdermalen applikation enthaltend gestoden
MX9101787A (es) 1990-10-29 1992-06-05 Alza Corp Formulaciones,metodos y dispositivos anticonceptivos transdermicos
US5512292A (en) 1990-10-29 1996-04-30 Alza Corporation Transdermal contraceptive formulations methods and devices
DE4210711A1 (de) 1991-10-31 1993-05-06 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De Transdermale therapeutische systeme mit kristallisationsinhibitoren
DE4336557C2 (de) 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
DE4405899A1 (de) * 1994-02-18 1995-08-24 Schering Ag Mittel zur transdermalen Applikation enthaltend Desogestrel
DE4405898A1 (de) 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
US5762956A (en) 1996-04-24 1998-06-09 Rutgers, The State University Of New Jersey Transdermal contraceptive delivery system and process
DE19629468A1 (de) * 1996-07-11 1998-01-15 Schering Ag Transdermale therapeutische Systeme
DE19827732A1 (de) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie
DE19906152B4 (de) 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Wirkstoffhaltige Laminate für Transdermalsysteme
NZ518723A (en) 1999-11-24 2004-04-30 Agile Therapeutics Inc Improved transdermal contraceptive delivery system and process
DE10053375C1 (de) * 2000-10-27 2002-01-24 Lohmann Therapie Syst Lts Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen
AU2002235155A1 (en) 2000-12-05 2002-06-18 Noven Pharmaceuticals, Inc. Crystallization inhibition of drugs in transdermal drug delivery systems
EP1216699A1 (de) 2000-12-21 2002-06-26 Schering Aktiengesellschaft Transdermalsystem enthaltend ein hochpotentes Gestagen
US20030165547A1 (en) * 2001-05-18 2003-09-04 Elisabeth Picard-Lesboueyries Cosmetic uses of 3beta-acetoxy-7-oxo-DHEA
DE10261696A1 (de) 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
ME00147B (me) * 2003-02-21 2010-10-10 Schering Ag Uv-stabilni transdermalni flasteri
UA89766C2 (en) * 2003-12-12 2010-03-10 Байер Шеринг Фарма Акциенгезельшафт Transdermal delivery system of gestodene
US8668925B2 (en) * 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
JP4965263B2 (ja) 2003-12-12 2012-07-04 バイエル ファーマ アクチエンゲゼルシャフト 浸透増強剤を必要としないホルモンの経皮送達
MX2007004315A (es) * 2004-10-08 2008-03-11 Noven Pharma Dispositivo para suministro transdermico de farmaco que incluye un respaldo oclusivo.
DE102004062182B4 (de) 2004-12-20 2007-06-06 Bayer Schering Pharma Ag Transdermales Pflaster mit Progesteron A-Spezifische Liganden (PRASL) als Wirkstoff
US8962013B2 (en) * 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
DE102005050729A1 (de) 2005-10-19 2007-04-26 Schering Ag Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption
AU2009302853B2 (en) * 2008-10-06 2014-09-11 Mylan Technologies, Inc. Amorphous rotigotine transdermal system

Also Published As

Publication number Publication date
IL224980A (en) 2017-07-31
PE20180198A1 (es) 2018-01-26
JP2016216500A (ja) 2016-12-22
AU2011298892B2 (en) 2015-03-12
US20140018751A1 (en) 2014-01-16
MY162768A (en) 2017-07-14
JP6104800B2 (ja) 2017-03-29
US20120082714A1 (en) 2012-04-05
TN2013000087A1 (en) 2014-06-25
PE20131138A1 (es) 2013-10-26
AP2013006787A0 (en) 2013-04-30
ZA201301389B (en) 2021-05-26
SG187941A1 (en) 2013-04-30
MX2013002602A (es) 2013-04-08
TW201217165A (en) 2012-05-01
EP2613771A1 (de) 2013-07-17
IL251124B (en) 2020-07-30
UA110217C2 (en) 2015-12-10
CU20130031A7 (es) 2013-05-31
IL251124A0 (en) 2017-04-30
EA032575B1 (ru) 2019-06-28
GT201300062A (es) 2015-01-16
JP2013536828A (ja) 2013-09-26
TWI576245B (zh) 2017-04-01
CO6690753A2 (es) 2013-06-17
WO2012031985A1 (de) 2012-03-15
AU2011298892A1 (en) 2013-03-28
US8557279B2 (en) 2013-10-15
AR082907A1 (es) 2013-01-16
US9060955B2 (en) 2015-06-23
CN103079549B (zh) 2016-11-02
ECSP13012477A (es) 2013-04-30
CR20130098A (es) 2013-05-15
AP3586A (en) 2016-02-10
BR112013005305A2 (pt) 2016-08-16
NZ607630A (en) 2015-02-27
DOP2013000053A (es) 2013-07-15
CN103079549A (zh) 2013-05-01
CA2810103A1 (en) 2012-03-15
EA201390246A1 (ru) 2013-09-30
PH12013500429A1 (en) 2019-10-07
KR20130114127A (ko) 2013-10-16
CL2013000636A1 (es) 2013-09-13
UY33590A (es) 2011-10-31
MA34581B1 (fr) 2013-10-02
CA2810103C (en) 2019-06-18
DE102010040299A1 (de) 2012-03-08
SG10201506927TA (en) 2015-10-29

Similar Documents

Publication Publication Date Title
EP3467323C0 (de) Befestigungssystem
FR2979441B3 (fr) Etui de protection
CO7000779A2 (es) Sistema de administración transdermica
BR112013016823A2 (pt) sistemas de expressão
EP3982242C0 (en) EVENT RECOGNITION
EP2523854A4 (en) MULTI-FUNCTION DEFROSTING / ANTIFREEZE SYSTEM
EP2554376A4 (en) SURFACE PROTECTION FILM
EP2526554A4 (en) RADIATION PROTECTION SYSTEM
BR112013012231A2 (pt) sistema de proteção contra perfuração
EP2559745A4 (en) SURFACE PROTECTION FILM
DK3413000T3 (da) Afskærmningssystem
FI20106192L (fi) Telineenkiinnitysjärjestely
EP2851923A4 (en) PROTECTION PART
BR112014015218A2 (pt) sistemas de afastadores cirúrgicos
DK2864523T3 (da) Katodisk beskyttelsessystem
GB201012398D0 (en) Protection system
EP2836624A4 (en) CATHODIC PROTECTION SYSTEM
FR2972247B3 (fr) Structure de protection flexible amelioree
PL2651567T3 (pl) Układ czworokątnego zraszacza
PL2565290T3 (pl) Balistyczny system ochronny
DE112010005767A5 (de) Insassenschutzsystem
EP2533983A4 (en) Rim protector
CU24172B1 (es) Sistemas terapéuticos transdérmicos con lámina de protección inhibidora de la cristalización
PT2761245T (pt) Sistema de proteção ativo
FR2961660B1 (fr) Barriere de protection souple

Legal Events

Date Code Title Description
FG Grant of patent